Clinical Trial NCT05876312
Trial
ADARx Pharmaceuticals – ADX-038-101 (NCT05876312)
Clinical trial ID
NCT05876312
Drug name
ADX-038
Company:
ADARx
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
1
Current status
Recruiting
Start
07/2023
Substance
siRNA duplex oligonucleotide
Research question
Safety, tolerability, pk and pd of adx- 038 in healthy volunteers and pnh- patients
Delivery method of drug
---
Frequency
---
Clinical trial locations
Australia